August 01, 2021
1 min watch
Save
VIDEO: Matossian comments on intense pulsed light treatment
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Cynthia A. Matossian, MD, FACS, discusses the recent FDA approval of Lumenis OptiLight for the treatment of patients with dry eye disease and meibomian gland dysfunction.